Alan W. Weber’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Alan W. Weber’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$6.1K	–	63
2016 Q3	$6.1K	Hold	10,000	–	–	﹤0.01%	59
2016 Q2	$5K	Hold	10,000	–	–	﹤0.01%	59
2016 Q1	$4K	Hold	10,000	–	–	﹤0.01%	56
2015 Q4	$4K	Hold	10,000	–	–	﹤0.01%	52
2015 Q3	$7K	Hold	10,000	–	–	0.01%	52
2015 Q2	$8K	Hold	10,000	–	–	0.01%	50
2015 Q1	$10K	Hold	10,000	–	–	0.01%	52
2014 Q4	$27K	Buy	+10,000	New	+$17.5K	0.02%	50

Other funds holding BDR

TCM

Tufton Capital Management Hunt Valley, Maryland $596M AUM 37.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alan W. Weber's BDR Position: Q4 2016 in Review

Alan W. Weber sold out of Blonder Tongue Laboratories Inc (BDR) in Q4 2016, closing a stake of 10,000 shares — an estimated $6.1K sold.

Alan W. Weber first reported a position in BDR in Q4 2014 and held it in 8 quarters. The position peaked at $27K in Q4 2014. 6 funds tracked by Wall St. Rank hold BDR as of Q4 2016.

Alan W. Weber reported no remaining Blonder Tongue Laboratories Inc position as of Q4 2016 after selling out during the quarter.
Alan W. Weber sold 10,000 Blonder Tongue Laboratories Inc shares in Q4 2016, an estimated $6.1K.
Alan W. Weber first reported a position in Blonder Tongue Laboratories Inc in Q4 2014 and held it in 8 quarters.
Alan W. Weber's Blonder Tongue Laboratories Inc position peaked at $27K in Q4 2014.
6 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q4 2016.

Based on Alan W. Weber's 13F filing for Q4 2016, filed 13 Feb 2017.